AKT1 and cancer: The observed prominence of Pathways in cancer and the PI3K-Akt signaling pathway suggests that Danshen may exert its therapeutic effects on the target disease primarily through its interactions with Pathways in cancer or the PI3K-Akt signaling pathway.